Medical Device

ENDRA Life Sciences will present new data from their photoacoustic imaging research at an upcoming molecular imaging conference.

ENDRA Life Sciences (NASDAQ:NDRA) will present new data from their photoacoustic imaging research at an upcoming molecular imaging conference.
As quoted in the press release:

ENDRA Life Sciences Chief Technology Officer Michael Thornton is scheduled to present on Saturday, September 16 at 1:30 p.m. Eastern time in Exhibit Hall A, Poster Session 4.
The poster presentation (P373) entitled, ‘The Effect of Low Frequency Noise Power on Image Quality in Photoacoustic Imaging Systems’ will demonstrate how increasing low frequencies by only 1.5% can increase the Contrast to Noise Ratio (CNR) by 150% thus enabling researchers to see anatomical detail at new depths. Concurrent with the new research, ENDRA will showcase its latest photoacoustic computed tomography system, the Nexus 128+, with proprietary 3D imaging technology in Booth #334.

Click here to read the full press release.

Source: www.accesswire.com

MARKETS

Markets
TSX18937.71+342.09
TSXV606.34+9.14
DOW31827.05+754.44
S&P 5003936.69+105.84
NASD11713.15+353.10
ASX6649.60-37.50

COMMODITIES

Commodities
Gold1711.29+1.27
Silver18.76-0.01
Copper3.30+0.01
Palladium1894.50+16.50
Platinum881.50+5.50
Oil103.51-0.71
Heating Oil3.59+0.02
Natural Gas7.24-0.03

DOWNLOAD FREE REPORTS

×